Abrdn Life Sciences Investors (HQL) Insider Trading & Ownership $14.35 +0.06 (+0.42%) (As of 12:02 PM ET) Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsDividendFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Abrdn Life Sciences Investors (NYSE:HQL) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage10.06%Number OfInsiders Buying(Last 12 Months)23Amount OfInsider Buying(Last 12 Months)$6.20 MNumber OfInsiders Selling(Last 12 Months)0 Get HQL Insider Trade Alerts Want to know when executives and insiders are buying or selling Abrdn Life Sciences Investors stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address HQL Insider Buying and Selling by Quarter Ad DarwinNew Year, New Opportunity! 2 AI Stocks Under $10 Ready to SoarAs we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.👉 Click here to access your FREE report now! Abrdn Life Sciences Investors Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/23/2024Bill MaherDirectorBuy650$15.37$9,990.50 7/16/2024Rose DimartinoDirectorBuy1,000$15.53$15,530.00 6/26/2024Saba Capital Management, L.P.Major ShareholderBuy100$14.07$1,407.00 6/24/2024Saba Capital Management, L.P.Major ShareholderBuy13,812$14.08$194,472.96 6/12/2024Saba Capital Management, L.P.Major ShareholderBuy2,400$13.88$33,312.00 6/10/2024Saba Capital Management, L.P.Major ShareholderBuy9,704$13.71$133,041.84 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 6/6/2024Saba Capital Management, L.P.Major ShareholderBuy9,598$13.80$132,452.40 6/4/2024Saba Capital Management, L.P.Major ShareholderBuy33,357$13.50$450,319.50 5/30/2024Saba Capital Management, L.P.Major ShareholderBuy669$13.05$8,730.45 5/28/2024Saba Capital Management, L.P.Major ShareholderBuy8,714$13.38$116,593.32 5/23/2024Saba Capital Management, L.P.Major ShareholderBuy1,303$13.50$17,590.50 5/15/2024Saba Capital Management, L.P.Major ShareholderBuy34,755$14.19$493,173.45 5/10/2024Saba Capital Management, L.P.Major ShareholderBuy57,862$13.86$801,967.32 5/8/2024Saba Capital Management, L.P.Major ShareholderBuy10,986$13.70$150,508.20 5/6/2024Saba Capital Management, L.P.Major ShareholderBuy10,713$13.62$145,911.06 5/2/2024Saba Capital Management, L.P.Major ShareholderBuy26,274$13.46$353,648.04 4/30/2024Saba Capital Management, L.P.Major ShareholderBuy16,573$13.13$217,603.49 4/26/2024Saba Capital Management, L.P.Major ShareholderBuy120,304$13.00$1,563,952.00 4/24/2024Saba Capital Management, L.P.Major ShareholderBuy20,529$13.12$269,340.48 4/22/2024Saba Capital Management, L.P.Major ShareholderBuy2,022$12.88$26,043.36 4/18/2024Saba Capital Management, L.P.Major ShareholderBuy81,738$12.80$1,046,246.40 4/9/2024Kathleen GoetzDirectorBuy400$13.32$5,328.00 1/2/2024Todd ReitDirectorBuy1,000$13.80$13,800.00 (Data available from 1/1/2013 forward) HQL Insider Trading Activity - Frequently Asked Questions Who is on Abrdn Life Sciences Investors's Insider Roster? The list of insiders at Abrdn Life Sciences Investors includes Bill Maher, Daniel R Omstead, Kathleen Goetz, Rose Dimartino, Saba Capital Management, L.P., and Todd Reit. Learn more on insiders at HQL. What percentage of Abrdn Life Sciences Investors stock is owned by insiders? 10.06% of Abrdn Life Sciences Investors stock is owned by insiders. Learn more on HQL's insider holdings. Which Abrdn Life Sciences Investors insiders have been buying company stock? The following insiders have purchased HQL shares in the last 24 months: Bill Maher ($9,990.50), Daniel R Omstead ($277,249.44), Kathleen Goetz ($5,328.00), Rose Dimartino ($15,530.00), Saba Capital Management, L.P. ($6,156,313.77), and Todd Reit ($13,800.00). How much insider buying is happening at Abrdn Life Sciences Investors? Insiders have purchased a total of 486,559 HQL shares in the last 24 months for a total of $6,478,211.71 bought. Abrdn Life Sciences Investors Key ExecutivesDr. Daniel R. Omstead M.S (Age 71)Ph.D., Principal Executive Officer, President and Trustee Mr. Peter BrannerChief Investment Officer More Insider Trading Tools from MarketBeat Related Companies CET Insider Trading MFIC Insider Trading NMFC Insider Trading BCSF Insider Trading BBDC Insider Trading HQH Insider Trading CGBD Insider Trading BTO Insider Trading ECC Insider Trading PDT Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Zeta Global Holdings Insiders Buy Stock After Short-ReportServiceNow: Will the High-Flyer Finally Split in 2024?Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in Buybacks This page (NYSE:HQL) was last updated on 12/3/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abrdn Life Sciences Investors Please log in to your account or sign up in order to add this asset to your watchlist. Share Abrdn Life Sciences Investors With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
